Advertisement
Advertisement

WST

WST logo

West Pharmaceutical Services, Inc.

347.35
USD
Sponsored
-4.94
-1.40%
Aug 13, 15:47 UTC -4
Open

West Pharmaceutical Services, Inc. Profile

About

West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.

Info & Links

CEO

Eric M. Green

Headquarters

530 HERMAN O. WEST DRIVE
EXTON, PA 19341, UNITED STATES

Industry

Medical Dental Supplies

Sector

Medical

Website

www.westpharma.com

Auditor

PricewaterhouseCoopers LLP

Share holders

468

Employees

10,800

West Pharmaceutical Services, Inc. Statistics

Valuation Measures

Market Capitalization2

24.44B

Enterprise Value

24.21B

Enterprise Value/EBITDA(ttm)

28.09

Price to Earnings Ratio(ttm)

41.34

Price to Sales(ttm)

7.43

Price to Book(mrq)

8.27

Price to Cash(ytd)

36.08

Profitability

Gross Margin(ttm)

36.79%

Operating Margin(ttm)

18.45%

Profit Margin(ttm)

16.97%

Return on Equity(ttm)

20.11%

Return on Invested Capital(ttm)

17.38%

Return on Assets(ttm)

14.83%

Income Statement

Revenue(ttm)

3.33B

Revenue Per Share(ttm)

47.27

Gross Profit(ttm)

1.22B

EBITDA(ttm)3

861.80M

Net Income Available to Common(ttm)

564.90M

Diluted EPS(ttm)

7.81

Share Statistics

Beta (5Y Monthly)

1.15

52-Week Change

44.79%

S&P 500 52-Week Change

20.68%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

70.38M

Dividend Yield

0.25%

Float4

69.95M

% Held by Insiders

0.60%

% Held by Institutions

93.90%

Balance Sheet

Total Cash(mrq)

435.80M

Total Cash Per Share(mrq)

6.19

Total Debt(mrq)

202.90M

Total Debt/Equity(mrq)

6.79%

Current Ratio(mrq)

2.82%

Quick Ratio(mrq)

2.12%

Book Value Per Share(mrq)

42.47

Cash Flow

Operating Cash Flow Per Share(ytd)

3.00

Free Cash Flow(ytd)

128.00M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement